Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics.

Ast J, Arvaniti A, Fine NHF, Nasteska D, Ashford FB, Stamataki Z, Koszegi Z, Bacon A, Jones BJ, Lucey MA, Sasaki S, Brierley DI, Hastoy B, Tomas A, D'Agostino G, Reimann F, Lynn FC, Reissaus CA, Linnemann AK, D'Este E, Calebiro D, Trapp S, Johnsson K, Podewin T, Broichhagen J, Hodson DJ.

Nat Commun. 2020 Jan 24;11(1):467. doi: 10.1038/s41467-020-14309-w.

2.

Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.

Brierley DI, Harman JR, Giallourou N, Leishman E, Roashan AE, Mellows BAD, Bradshaw HB, Swann JR, Patel K, Whalley BJ, Williams CM.

J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):844-859. doi: 10.1002/jcsm.12426. Epub 2019 Apr 29.

3.

Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food.

Holt MK, Richards JE, Cook DR, Brierley DI, Williams DL, Reimann F, Gribble FM, Trapp S.

Diabetes. 2019 Jan;68(1):21-33. doi: 10.2337/db18-0729. Epub 2018 Oct 2.

4.

GLP-1 neurons form a local synaptic circuit within the rodent nucleus of the solitary tract.

Card JP, Johnson AL, Llewellyn-Smith IJ, Zheng H, Anand R, Brierley DI, Trapp S, Rinaman L.

J Comp Neurol. 2018 Oct 1;526(14):2149-2164. doi: 10.1002/cne.24482. Epub 2018 Sep 19.

5.

A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9-tetrahydrocannabinol, elicits hyperphagia in rats.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Behav Pharmacol. 2017 Jun;28(4):280-284. doi: 10.1097/FBP.0000000000000285.

PMID:
28125508
6.

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3603-13. doi: 10.1007/s00213-016-4397-4. Epub 2016 Aug 9.

7.

Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Psychopharmacology (Berl). 2016 Jan;233(2):243-54. doi: 10.1007/s00213-015-4100-1. Epub 2015 Oct 6.

PMID:
26439367
8.

Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell.

Brierley DI, Davidson C.

J Psychopharmacol. 2013 Jan;27(1):98-108. doi: 10.1177/0269881112463125. Epub 2012 Oct 17.

PMID:
23076833
9.

Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment.

Brierley DI, Davidson C.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):263-72. doi: 10.1016/j.pnpbp.2012.06.001. Epub 2012 Jun 9. Review.

PMID:
22691716
10.

Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli.

Brischoux F, Chakraborty S, Brierley DI, Ungless MA.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4894-9. doi: 10.1073/pnas.0811507106. Epub 2009 Mar 4.

Supplemental Content

Loading ...
Support Center